|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Ocugen Inc. (OCGN)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-10-11 Purchase |
2019-10-15 3:03 pm |
Ocugen Inc. | OCGN | Zhang Junge Director |
4,000 | $1.48 | $5,920 | 212,863 (Indirect Direct) |
View |
| 2019-10-02 Purchase |
2019-10-04 1:36 pm |
Ocugen Inc. | OCGN | Subramanian Sanjay CFO |
5,000 | $1.88 | $9,400 | 23,970 (Direct) |
View |
| 2019-09-30 Purchase |
2019-10-04 1:34 pm |
Ocugen Inc. | OCGN | Zhang Junge Director |
31,078 | $3.094 | $96,141 | 212,863 (Indirect Direct) |
View |
| 2019-01-11 Sale |
2019-01-15 5:21 pm |
HISTOGENICS CORP | HSGX | KIRK RANDAL J INTREXON CORP 10% Owner |
998,204 | $0.1591 | $158,772 | 2,438,770 (Indirect) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
230,768 | $0 | $0 | 245,563 (Indirect Direct) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
538,460 | $0 | $0 | 3,610,570 (Direct) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
HISTOGENICS CORP | HSGX | Lewis Michael Director, 10% Owner |
538,460 | $0 | $0 | 3,610,570 (Indirect) |
View |
| 2018-05-16 Purchase |
2018-05-18 5:47 pm |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
2,000 | $2.15 | $4,300 | 7,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-10-02 Option Award |
2019-10-04 1:36 pm |
N/A 2029-10-01 |
Ocugen Inc. | OCGN | Subramanian Sanjay CFO |
23,970 | $2.19 | 23,970 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:27 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
403,845 | $0 | 5,258,859 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:27 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
1,244,444 | $0 | 5,258,859 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:27 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
403,845 | $0.01 | 5,258,859 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:27 pm |
2016-11-22 2021-11-22 |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
1,244,444 | $0.01 | 5,258,859 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | Lewis Michael Director |
403,845 | $0 | 5,258,859 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | Lewis Michael Director |
1,244,444 | $0 | 5,258,859 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | Lewis Michael Director |
403,845 | $0.01 | 5,258,859 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2016-11-22 2021-11-22 |
HISTOGENICS CORP | HSGX | Lewis Michael Director |
1,244,444 | $0.01 | 5,258,859 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
173,076 | $0 | 418,639 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
33,333 | $0 | 418,639 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
33,333 | $0 | 418,639 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
N/A N/A |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
111,111 | $0 | 418,639 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
173,076 | $0.01 | 418,639 (Direct) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2016-11-22 2021-11-22 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
33,333 | $0.01 | 418,639 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2016-11-22 2021-11-22 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
33,333 | $0.01 | 418,639 (Indirect) |
View |
| 2019-02-08 Exercise |
2019-02-11 4:26 pm |
2016-11-22 2021-11-22 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
111,111 | $0.01 | 418,639 (Indirect) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
173,076 | $0.7 | 245,563 (Direct) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | Wilmslow Estates Ltd 10% Owner |
403,845 | $0.7 | 3,610,570 (Direct) |
View |
| 2018-10-10 Purchase |
2018-10-11 4:30 pm |
2018-10-10 2023-10-10 |
HISTOGENICS CORP | HSGX | Lewis Michael Director, 10% Owner |
403,845 | $0.7 | 3,610,570 (Indirect) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:03 pm |
N/A 2028-07-30 |
HISTOGENICS CORP | HSGX | Kelley Lynne E Chief Medical Officer |
200,000 | $2.21 | 200,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:03 pm |
N/A 2028-07-30 |
HISTOGENICS CORP | HSGX | Kelley Lynne E Chief Medical Officer |
200,000 | $0.568 | 200,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2023-12-10 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
27,767 | $7.13 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2023-12-10 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
27,767 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2025-02-25 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
49,100 | $9.96 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2025-02-25 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
49,100 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2015-07-28 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
50,000 | $6.11 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2015-07-28 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
50,000 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2026-02-25 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
25,000 | $2.56 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2026-02-25 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
25,000 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2027-02-13 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
75,000 | $1.72 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2027-02-13 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
75,000 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2027-10-09 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
50,000 | $2.12 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2027-10-09 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
50,000 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
115,000 | $2.63 | 115,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
115,000 | $0.568 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2025-02-25 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard COO |
30,000 | $9.96 | 115,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2027-06-04 |
HISTOGENICS CORP | HSGX | Haut Donald Chief Business Officer |
195,000 | $1.67 | 195,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2027-06-04 |
HISTOGENICS CORP | HSGX | Haut Donald Chief Business Officer |
195,000 | $0.568 | 195,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:01 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Haut Donald Chief Business Officer |
105,000 | $2.63 | 195,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:01 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Haut Donald Chief Business Officer |
105,000 | $0.568 | 195,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2025-07-01 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
110,000 | $6.37 | 130,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2015-07-01 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
110,000 | $0.568 | 130,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2026-02-25 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
28,000 | $2.56 | 130,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2026-02-25 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
28,000 | $0.568 | 130,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2027-02-13 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
50,000 | $1.72 | 130,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2027-02-13 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
50,000 | $0.568 | 130,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
130,000 | $2.63 | 130,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
130,000 | $0.568 | 130,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2025-07-01 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
30,000 | $6.37 | 130,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2024-04-29 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
197,435 | $7.99 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2024-04-29 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
197,435 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2024-07-16 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
38,220 | $8.97 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2024-07-16 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
38,220 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2025-02-26 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
104,000 | $9.96 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2025-02-26 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
104,000 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2026-12-16 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
175,000 | $1.58 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2026-12-16 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
175,000 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2027-02-14 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
175,000 | $1.72 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2027-02-14 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
175,000 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
300,000 | $2.63 | 300,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 5:00 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
300,000 | $0.568 | 300,000 (Direct) |
View |
| 2018-10-01 Disposition |
2018-10-03 5:00 pm |
N/A 2025-02-26 |
HISTOGENICS CORP | HSGX | Gridley Adam CEO |
60,000 | $9.96 | 300,000 (Direct) |
View |
| 2018-07-31 Option Award |
2018-08-01 4:36 pm |
N/A 2028-07-30 |
HISTOGENICS CORP | HSGX | Kelley Lynne E Chief Medical Officer |
200,000 | $2.21 | 200,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:42 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | GILL DAVID N Director |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:41 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | Lewis Michael Director, 10% Owner |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:41 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | RAKIN KEVIN Director |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:41 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | Kong Garheng Director |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:41 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | Baltzell Joshua J Director |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-06-15 Option Award |
2018-06-19 4:41 pm |
N/A 2028-06-14 |
HISTOGENICS CORP | HSGX | JOHNSON JOHN Director |
25,000 | $2.97 | 25,000 (Direct) |
View |
| 2018-04-16 Option Award |
2018-04-18 5:10 pm |
N/A 2028-04-15 |
HISTOGENICS CORP | HSGX | Washer Susan B. Director |
25,000 | $2.84 | 25,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:51 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Kennedy Stephen Richard CTO |
115,000 | $2.63 | 115,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:51 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Lieber Jonathan I CFO |
130,000 | $2.63 | 130,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:51 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Haut Donald Chief Business Officer |
105,000 | $2.63 | 105,000 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-21 4:49 pm |
N/A 2028-02-15 |
HISTOGENICS CORP | HSGX | Gridley Adam Director |
300,000 | $2.63 | 300,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 23 Oct 2019 20:57:26 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |